Figure 3
Figure 3. VWF/platelet complexes circulate in the blood of VWD type 2B mice. Blood smears prepared with blood collected from mice expressing either wt-mVWF (A), p.R1306Q-mVWF (B-C), or p.V1316M-mVWF (D). Mice had normal or slightly low platelet counts (A-B) or were thrombocytopenic (C-D). Platelets were detected by staining for the CD41 surface marker (red), and VWF (green) was detected with primary rabbit anti-human VWF antibody followed by a secondary AlexaFluor 488–goat anti-rabbit antibody. Original magnification is ×100. (A-B) Single platelets can be observed, and no VWF at the platelet surface could be detected. (C-D) Thrombocytopenic mice display circulating single platelets and platelet aggregates, both of which are characterized by the presence of VWF at the platelet surface.

VWF/platelet complexes circulate in the blood of VWD type 2B mice. Blood smears prepared with blood collected from mice expressing either wt-mVWF (A), p.R1306Q-mVWF (B-C), or p.V1316M-mVWF (D). Mice had normal or slightly low platelet counts (A-B) or were thrombocytopenic (C-D). Platelets were detected by staining for the CD41 surface marker (red), and VWF (green) was detected with primary rabbit anti-human VWF antibody followed by a secondary AlexaFluor 488–goat anti-rabbit antibody. Original magnification is ×100. (A-B) Single platelets can be observed, and no VWF at the platelet surface could be detected. (C-D) Thrombocytopenic mice display circulating single platelets and platelet aggregates, both of which are characterized by the presence of VWF at the platelet surface.

Close Modal

or Create an Account

Close Modal
Close Modal